Sotera Health Company
General ticker "SHC" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $4.4B (TTM average)
Sotera Health Company follows the US Stock Market performance with the rate: 45.9%.
Estimated limits based on current volatility of 1.4%: low 18.69$, high 19.21$
Factors to consider:
- Total employees count: 3000 (0.0%) as of 2025
- US accounted for 56.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Regulatory and compliance, Litigation risks, Market demand decline, Cybersecurity threats
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [14.89$, 24.05$]
- 2026-12-31 to 2027-12-31 estimated range: [15.25$, 24.68$]
Financial Metrics affecting the SHC estimates:
- Positive: with PPE of 20.5 at the end of fiscal year the price was low
- Positive: Operating profit margin, % of 33.75 > 18.77
- Positive: Interest expense per share per price, % of 3.12 <= 3.34
- Negative: Shareholder equity ratio, % of 18.57 <= 18.97
- Negative: negative Industry operating cash flow (median)
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 2.33
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
- Negative: Investing cash flow per share per price, % of -2.70 <= -0.64
Short-term SHC quotes
Long-term SHC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,049.29MM | $1,100.44MM | $1,163.62MM |
| Operating Expenses | $772.60MM | $802.82MM | $770.85MM |
| Operating Income | $276.69MM | $297.63MM | $392.77MM |
| Non-Operating Income | $-170.66MM | $-183.75MM | $-245.27MM |
| Interest Expense | $142.88MM | $164.69MM | $155.72MM |
| Income(Loss) | $106.03MM | $113.87MM | $147.51MM |
| Taxes | $54.65MM | $69.48MM | $69.56MM |
| Net Income(Loss)* | $51.38MM | $44.40MM | $77.95MM |
| Stockholders Equity | $443.73MM | $404.91MM | $606.03MM |
| Inventory | $48.32MM | $49.16MM | $59.39MM |
| Assets | $3,130.42MM | $3,071.65MM | $3,263.19MM |
| Operating Cash Flow | $-147.73MM | $224.16MM | $287.19MM |
| Capital expenditure | $214.97MM | $179.07MM | $138.02MM |
| Investing Cash Flow | $-214.91MM | $-179.00MM | $-135.14MM |
| Financing Cash Flow | $265.96MM | $-50.56MM | $-100.53MM |
| Earnings Per Share** | $0.18 | $0.16 | $0.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.